## Abstract **Background** Psoriasis is a chronic, relapsing skin disease that may require multiple treatment courses. Alefacept targets the memory T cells implicated in psoriasis pathogenesis. This open‐label study evaluated the safety and tolerability, efficacy, and pharmacodynamics of repeat cou
Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
✍ Scribed by P.C.M. Van De Kerkhof; J. Berth-Jones; C.E.M. Griffiths; P.V. Harrison; H. Hönigsmann; R. Marks; R. Roelandts; E. Schöpf; C. Trompke
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 122 KB
- Volume
- 146
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have previously reported the effectiveness of high-dose calcipotriol in extensive psoriasis. We now report the long-term outcome in patients following this treatment. Twenty-eight patients with severe psoriasis were treated as in-patients with high-dose topical calcipotriol for 2 weeks. There was
## Background: Numerous studies have shown that the additional administration of topical or systemic antipsoriatic agents might serve as an effective means to increase the efficacy of photochemotherapy [psoralen plus ultraviolet (uv) a (puva)] for psoriasis. ## Objectives: To compare the therapeu
## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a